Abstract
A novel series of 3-methyl-1-benzofuran derivatives were synthesized and screened in vitro for their antiproliferative activity against two human NSCLC cell lines (NSCLC-N6 mutant p53 and A549 wild type p53). Most promising compounds presented a structural analogy with the west part of cercosporamide, a natural product of biological interest. In particular, compounds 10, 12 and 31 showed cytotoxic activities at micromolar concentrations (IC₅₀ < 9.3 μM) and compounds 13, 18 and 32 displayed moderate IC₅₀ values (25-40 μM).
Keywords:
Antiproliferative activity; Benzofuran; Cercosporamide; NSCLC.
Copyright © 2013 Elsevier Masson SAS. All rights reserved.
MeSH terms
-
Antineoplastic Agents / administration & dosage
-
Antineoplastic Agents / chemical synthesis*
-
Antineoplastic Agents / chemistry
-
Antineoplastic Agents / pharmacology*
-
Benzofurans / chemical synthesis
-
Benzofurans / chemistry*
-
Benzofurans / pharmacology*
-
Carcinoma, Non-Small-Cell Lung / drug therapy*
-
Carcinoma, Non-Small-Cell Lung / pathology
-
Cell Line, Tumor
-
Cell Proliferation / drug effects
-
Dose-Response Relationship, Drug
-
Drug Screening Assays, Antitumor
-
Humans
-
Lung Neoplasms / drug therapy*
-
Lung Neoplasms / pathology
-
Molecular Structure
-
Structure-Activity Relationship
Substances
-
Antineoplastic Agents
-
Benzofurans
-
cercosporamide
-
benzofuran